These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36739417)

  • 41. Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island.
    Zang X; Bessey SE; Krieger MS; Hallowell BD; Koziol JA; Nolen S; Behrends CN; Murphy SM; Walley AY; Linas BP; Schackman BR; Marshall BDL
    JAMA Netw Open; 2022 Nov; 5(11):e2241174. PubMed ID: 36350649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.
    Bass SB; Kelly PJA; Pandit-Kerr S; Pilla J; Morris K; Larsen E; Wisdom JP; Torralva PR
    Front Public Health; 2022; 10():882421. PubMed ID: 35937263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment.
    Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR
    Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469
    [No Abstract]   [Full Text] [Related]  

  • 44. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased solitary drug use during COVID-19: An unintended consequence of social distancing.
    Schneider KE; Allen ST; Rouhani S; Morris M; Haney K; Saloner B; Sherman SG
    Int J Drug Policy; 2023 Jan; 111():103923. PubMed ID: 36521196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
    Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada.
    Minoyan N; Høj SB; Zolopa C; Vlad D; Bruneau J; Larney S
    Harm Reduct J; 2022 Apr; 19(1):38. PubMed ID: 35436936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond.
    Green TC; Kaplowitz E; Langdon K; Hughto JMW; Goedel WC; Czynski AJ; Fraser G; Rich J
    R I Med J (2013); 2021 Apr; 104(3):22-26. PubMed ID: 33789404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Social context and perspectives of non-medical prescription opioid use among young adults in Rhode Island: A qualitative study.
    Yedinak JL; Kinnard EN; Hadland SE; Green TC; Clark MA; Marshall BD
    Am J Addict; 2016 Dec; 25(8):659-665. PubMed ID: 28051839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19.
    McCrae K; Glegg S; Goyer MÉ; Le Foll B; Brar R; Sutherland C; Fairbairn N
    Harm Reduct J; 2022 Jul; 19(1):77. PubMed ID: 35836189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential impacts of COVID-19 and associated responses on the health, social well-being and food security of users of supportive social and health programs during the COVID-19 pandemic: A qualitative study.
    Mejia-Lancheros C; Alfayumi-Zeadna S; Lachaud J; O'Campo P; Gogosis E; Da Silva G; Stergiopoulos V; Hwang SW; Thulien N
    Health Soc Care Community; 2022 Nov; 30(6):e4332-e4344. PubMed ID: 35524402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.
    Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM
    J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cross-national study of factors associated with women's perinatal mental health and wellbeing during the COVID-19 pandemic.
    Basu A; Kim HH; Basaldua R; Choi KW; Charron L; Kelsall N; Hernandez-Diaz S; Wyszynski DF; Koenen KC
    PLoS One; 2021; 16(4):e0249780. PubMed ID: 33882096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.
    Collins AB; Boyd J; Mayer S; Fowler A; Kennedy MC; Bluthenthal RN; Kerr T; McNeil R
    Int J Drug Policy; 2019 Nov; 73():199-207. PubMed ID: 31542327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Public libraries as partners in confronting the overdose crisis: A qualitative analysis.
    Lowenstein M; Feuerstein-Simon R; Sheni R; Dupuis R; Kinsey EW; Luna Marti X; Cannuscio C
    Subst Abus; 2021; 42(3):302-309. PubMed ID: 31852402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.